Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Return on Invested Capital (2021 - 2023)

Rani Therapeutics Holdings' Return on Invested Capital history spans 3 years, with the latest figure at 0.02% for Q4 2023.

  • On a quarterly basis, Return on Invested Capital fell 1.0% to 0.02% in Q4 2023 year-over-year; TTM through Dec 2023 was 0.02%, a 1.0% decrease, with the full-year FY2022 number at 0.01%, up 10.0% from a year prior.
  • Return on Invested Capital came in at 0.02% for Q4 2023, down from 0.02% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.0% in Q2 2021, with the low at 0.07% in Q3 2021.
  • Historically, Return on Invested Capital has averaged 0.01% across 3 years, with a median of 0.01% in 2022.
  • Peak annual rise in Return on Invested Capital hit 7bps in 2022, while the deepest fall reached -1bps in 2022.
  • Year by year, Return on Invested Capital stood at 0.0% in 2021, then plummeted by -94bps to 0.01% in 2022, then tumbled by -152bps to 0.02% in 2023.
  • Business Quant data shows Return on Invested Capital for RANI at 0.02% in Q4 2023, 0.02% in Q3 2023, and 0.01% in Q2 2023.